Browse 142 market data tables and 39 figures spread through 177 pages and in-depth TOC on “Sleep Apnea Devices Market” —
Early buyers will receive 10% customization on this report.
This report studies the global sleep apnea devices market for the forecast period of 2016 to 2021. This market is expected to reach USD 6.70 Billion by 2021 from USD 4.59 Billion in 2016, growing at a CAGR of 7.8%.
The global sleep apnea devices market is segmented on the basis of product, end user, and region.
On the basis of product, the market is segmented into therapeutic devices and diagnostic devices. In 2016, the therapeutic devices segment is expected to command the largest share of the market. This segment is also expected to register the highest CAGR from 2016 to 2021. The large share of this segment can be attributed to the wide use of these compact devices in the treatment of sleep apnea.
On the basis of therapeutic devices, the market is segmented into PAP devices, facial interfaces, oxygen concentrators, adaptive servo-ventilation instruments, airway clearance systems, accessories, and oral appliances. The PAP devices segment is estimated to account for the largest share of the global sleep apnea therapeutic devices market in 2016. Technological advancements have made these devices compact, comfortable, and easy to use to ensure better patient compliance; this is expected to ensure steady growth for the PAP devices market in the coming years. The oral appliances segment is projected to register the highest CAGR in the forecast period.
Download the PDF Brochure@
On the basis of diagnostic devices, the market is segmented into PSG devices, respiratory polygraphs, single-channel screening devices, and actigraphy systems. The PSG devices segment is estimated to account for the largest share of the global sleep apnea diagnostic devices market in 2016. The single-channel screening devices segment is projected to register the highest CAGR during the forecast period. The high growth rate of single-channel screening devices can be attributed to its noninvasive and painless cardiorespiratory monitors that are used to assess the oxygen saturation level of arterial blood.
Based on end user, the sleep apnea devices market is segmented into home care settings and sleep laboratories & hospitals. The home care settings segment is projected to register the highest CAGR during the forecast period. This growth can be attributed to the preference for home care in sleep apnea diagnosed patients.
On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to account for the largest share of the global sleep apnea devices market, followed by Europe. Europe is projected to register the highest CAGR in the forecast period. Factors such as the new legislation of PAP devices, growing funding and grants for sleep apnea devices and treatment, introduction of new devices in the European market, and focus of industry players are likely to boost market growth in the region.
The prominent players in the global sleep apnea devices market were ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand) in 2015. These companies are dominant in the market mainly due to their well-established presence in the field of sleep apnea devices, presence in over 50 countries, high R&D investments, and strong sales and distribution force. Other players include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Weinmann Medical Devices GmbH (Germany), Whole You, Inc. (U.S.), BMC Medical Co., Ltd. (China), DeVilbiss Healthcare (U.S.), and Braebon Medical Corporation (Canada).
Talk to Our Research Experts for More Details@
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
Name: Mr. Rohan
Email: Send Email
Release ID: 278008